Sichenzia Ross Ference LLP Represents Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) in Offering of $1.2 Million American Depositary Shares
Press Release – New York, NY – May 23, 2019 – Sichenzia Ross Ference LLP announced today that it represented Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE), a diversified molecular diagnostics company, in a registered direct offering of American Depositary Shares (“ADSs”) and warrants to purchase ADSs. The Company received gross proceeds of approximately $1,200,000.
The Sichenzia Ross Ference LLP team was led by Partners Darrin Ocasio and Avital Perlman, Of Counsel Jeff Cahlon and Associate Grant Levine.
- Sichenzia Ross Ference LLP Represents A.G.P./ Alliance Global Partners as Placement Agent in $15M Registered Direct Offering of Arcimoto, Inc. - November 24, 2020
- Founding Partner Marc J. Ross, Esq. Quoted Regarding Cannabis SPACs Post U.S. Presidential Elections - November 23, 2020
- 2020 Income Tax Rates and Deductions - November 19, 2020